Scarica l'app Stockscreener
3.48
1.14%
-0.04
Dopo l'orario di chiusura:
3.49
0.01
+0.29%
Precedente Chiudi:
$3.52
Aprire:
$3.52
Volume 24 ore:
414.33K
Relative Volume:
0.37
Capitalizzazione di mercato:
$163.93M
Reddito:
$144.98M
Utile/perdita netta:
$-104.19M
Rapporto P/E:
-1.4702
EPS:
-2.367
Flusso di cassa netto:
$-82.90M
1 W Prestazione:
-5.18%
1M Prestazione:
-19.44%
6M Prestazione:
-45.11%
1 anno Prestazione:
-41.41%
Intervallo 1D:
$3.335
$3.54
Intervallo di 1 settimana:
$3.335
$3.86
Portata 52W:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Nome
Quanterix Corp
Settore
Industria
Telefono
617-301-9400
Indirizzo
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.48 | 172.88M | 144.98M | -104.19M | -82.90M | -2.367 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | Iniziato | Scotiabank | Sector Outperform |
| 2023-09-25 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-15 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-08-09 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-04 | Iniziato | Goldman | Sell |
Mostra tutto
Quanterix Corp Borsa (QTRX) Ultime notizie
Quanterix Corp (QTRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quanterix Corp (QTRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quanterix Corp (QTRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quanterix Corp (QTRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Quanterix Corp (QTRX) Income Statement - TradingKey
Quanterix Corp (QTRX) Cash Flow - TradingKey
QTRX|Quanterix Corp|Price:3.665|Chg%:-0.005 - TradingKey
Quanterix Corp (QTRX) Balance Sheet - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QTRX|Quanterix Corp|Price:3.530|Chg%:-0.140 - TradingKey
Quanterix Corp (QTRX) Institutional Confidence - TradingKey
Quanterix Corp (QTRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
QTRX|Quanterix Corp|Price:3.670|Chg%:-0.250 - TradingKey
Biomarker Collaboration and Licensing Deals Report 2016-2026Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Yahoo Finance
Quanterix stock trades lower despite stronger revenue and margin progress - Ad-hoc-news.de
Form 4 Quanterix Corp For: 16 July By Investing.com - Investing.com Nigeria
Quanterix Corp (QTRX) CTO converts 1,558 RSUs, withholds shares for taxes - Stock Titan
Quanterix Corp (NASDAQ: QTRX) grants 141,820 RSUs to its CFO - Stock Titan
Quanterix CFO’s 141,820-Share Award Vests Over Four Years - Stock Titan
Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv - GuruFocus
Anthem Blue Cross covers Quanterix Alzheimer’s blood test - Investing.com
Quanterix test found preclinical Alzheimer’s evidence in 20% of cognitively normal adults - Stock Titan
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages - Yahoo Finance
Jason F. Faessler Net Worth (2026) - GuruFocus
Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets - Yahoo Finance
Form 4 Quanterix Corp For: 9 July By Investing.com - Investing.com Nigeria
Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX) - Stock Titan
Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares - Stock Titan
TRIB, QTRX, RCON: Why these stocks are surging after-hours today - MSN
Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees - Stock Titan
QTRX Forecast — Price Target — Prediction for 2027 - TradingView
Quanterix Corp sets out growth plans, shares trade on Nasdaq - ad-hoc-news.de
Quanterix Stock Is Popping In Pre-Market: Here's Why - Sahm
Form 4 Quanterix Corp For: 23 June - Investing.com UK
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today - TradingView
Form 4 Quanterix Corp For: 23 June By Investing.com - Investing.com Nigeria
Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld - Stock Titan
Quanterix (QTRX) CFO Jason Faessler files initial Form 3 ownership - Stock Titan
QTRXQuanterix Corp Volatility & Greeks - Finviz
Quanterix Corp (QTRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quanterix (QTRX) CTO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Biotech Quanterix gives new staff 336,804 stock units over 4 years - Stock Titan
Quanterix CCO Benjamin Meadows buys $9,695 in company stock By Investing.com - Investing.com Nigeria
Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade - Stock Titan
Quanterix (QTRX) CCO Benjamin Meadows reports options, RSUs and PSUs in Form 3 - Stock Titan
Quanterix Corp Azioni (QTRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quanterix Corp Azioni (QTRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Sriram Vandana | Chief Financial Officer |
Sep 12 '25 |
Buy |
4.79 |
4,150 |
19,878 |
87,200 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):